Navigation Links
Custom Spine Announces Lew Bennett as President
Date:1/20/2009

PARSIPPANY, N.J., Jan. 20 /PRNewswire/ -- Custom Spine announced today that Lew Bennett has been named President and will serve on the Board of Directors. Mr. Bennett brings with him over 48 years experience in the medical device industry. Having retired and re-entered the market six times, Mr. Bennett's love of a new challenge and dedication to the medical device industry is clear. Custom Spine founder and CEO, Mahmoud Abdelgany commented, "We are really excited to have Lew Bennett taking the helm of Custom Spine. He brings to the company a deep knowledge of the market and a passion for success."

Mr. Bennett has held senior executive positions with several companies in the orthopedic and spine industry including: Executive Vice President, Officer, and Board Member of NuVasive, Inc.; early investor, Executive Vice President, Officer and Director of Sofamor Danek (now a division of Medtronic, Inc.); President, General Medical Division, Smith & Nephew, Inc. and President of Dillion Manufacturing. In addition, he was one of the founders of Howmedica Corporation (now Stryker Howmedica Osteonics). Prior to founding Howmedica, he was Regional Manager for Ethicon Corporation, a division of Johnson & Johnson. Mr. Bennett currently serves on the Boards of Directors for Custom Spine and HydroCision.

Mr. Bennett's proven success and love of developing people have afforded him the opportunity to be the guest speaker at numerous medical conferences and to lecture at over 300 orthopedic and neurological resident programs. He has consulted for over 550 orthopedic and neurological practices and universities.

Custom Spine develops advanced fixation and interbody systems with unique features that increase the ease of implantation for the surgeon and provide added benefits for the patient. When asked about Custom Spine products Mr. Bennett commented, "Custom Spine's engineers have developed innovative produc
'/>"/>

SOURCE Custom Spine
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
2. Customized virus kills brain tumor stem cells that drive lethal cancer
3. Whole Foods Market(R) Donates $25,000, for Midwest Farmers - Hoping to Match an Additional $10,000, via Customer Donations
4. Blue Cross Blue Shield of Michigan Offers New Approach to Customer Group Wellness
5. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
6. J.D. Power and Associates Reports: CIGNA HealthCare Recognized for Call Center Customer Satisfaction Excellence For a Second Consecutive Year
7. Nucletron Announces Management Buy-Out to More Effectively Meet the Demands of Its Customers and the Radiation Therapy Community
8. Texas Aviation Services: Over 20 Years of Creating Flying Emergency Rooms for Airborne EMS Customers in US and Latin America
9. LodgeNet Deploys Customized Kid Friendly Solution With Childrens Hospital of Pittsburgh of UPMC
10. New Technology at Unitrin Direct Gives Customers an Alternative to Waiting
11. Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of ... area has treated just about every type of injury that can ... for those same twenty-plus years, the team at Doctors on ... the best possible doctor. With the combined breadth of ...
(Date:1/22/2015)... Joan Lunden, award-winning American journalist, beloved ... upcoming 32nd Annual Miami Breast Cancer Conference ... LLC (PER®) , shares that “a fast-growing, virulent” cancer ... she had not followed up her clean mammogram with ...
(Date:1/22/2015)... Calif. (PRWEB) January 22, 2015 ... Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were ... their leadership in advancing biotechnology, biomedical science, medical ... and Olsen each received the “2014 Life Sciences ...
(Date:1/22/2015)... Florida (PRWEB) January 22, 2015 IsoComforter, Inc. ... therapy machine with patented IsoTube design to treat specific body ... introduced the most progressive and easy to use patented cold ... post-operative and sports related orthopedic and muscle injuries. IsoComforter ...
(Date:1/22/2015)... 22, 2015 Payday lending practices in ... and cause financial distress to the states that permit ... Howard University’s Center on Race and Wealth. , While ... activity, payday loans at the same time substantially depress ...
Breaking Medicine News(10 mins):Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
... a Boston based venture-backed technology startup has been ... Entrepreneurship Conference (WEC25). The WEC25 Expo is an ... products to a vast network of VCs and ... in the identity and access management industry to ...
... Feb. 4 Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV ... for the first quarter of fiscal 2009, ended December 31, ... consolidated net loss of $7.6 million or $0.10 per share ... to revenues of $16.4 million and a consolidated net loss ...
... Hospitals of America (PHA) congratulates Congress on its ... healthcare access and insurance to millions of children ... "Congress recognized that the SCHIP bill was too ... address the contentious issue of physician ownership of ...
... Young Innovations, Inc.,(Nasdaq: YDNT ) today announced ... Sales for the fourth quarter of ... from the $25.0 million reported in the fourth quarter,of 2007. ... the,fourth quarter of 2007 to $4.8 million in the fourth ...
... LOS ANGELES, Feb. 4 The Elton John AIDS ... perform at the 17th Annual Elton John AIDS Foundation ... 2009, at the Pacific Design Center in Los Angeles. ... and David Furnish, and will be co-sponsored by Chopard, ...
... MedCath Corporation,(Nasdaq: MDTH ), a healthcare provider ... of cardiovascular disease,today announced its operating results for its first ... Highlights, -- Net revenue ... -- Adjusted EBITDA of $17.2 million, ...
Cached Medicine News:Health News:Delfigo Security Selected as One of Twenty Five Most Promising Startups by The Wharton Entrepreneurship Conference 2Health News:Delfigo Security Selected as One of Twenty Five Most Promising Startups by The Wharton Entrepreneurship Conference 3Health News:Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results 2Health News:Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results 3Health News:Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results 4Health News:Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results 5Health News:Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results 6Health News:Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results 7Health News:Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results 8Health News:Physician Hospitals of America (PHA) Congratulates Congress on its Passage of a 'Clean' SCHIP Children's Health Bill 2Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 2Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 3Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 4Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 5Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 6Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 7Health News:Three-Time Grammy Nominee Raphael Saadiq to Perform at 17th Annual Elton John AIDS Foundation Academy Awards(R) Viewing Party 2Health News:Three-Time Grammy Nominee Raphael Saadiq to Perform at 17th Annual Elton John AIDS Foundation Academy Awards(R) Viewing Party 3Health News:Three-Time Grammy Nominee Raphael Saadiq to Perform at 17th Annual Elton John AIDS Foundation Academy Awards(R) Viewing Party 4Health News:MedCath Corporation Reports First Quarter Earnings 2Health News:MedCath Corporation Reports First Quarter Earnings 3Health News:MedCath Corporation Reports First Quarter Earnings 4Health News:MedCath Corporation Reports First Quarter Earnings 5Health News:MedCath Corporation Reports First Quarter Earnings 6Health News:MedCath Corporation Reports First Quarter Earnings 7Health News:MedCath Corporation Reports First Quarter Earnings 8Health News:MedCath Corporation Reports First Quarter Earnings 9Health News:MedCath Corporation Reports First Quarter Earnings 10Health News:MedCath Corporation Reports First Quarter Earnings 11Health News:MedCath Corporation Reports First Quarter Earnings 12Health News:MedCath Corporation Reports First Quarter Earnings 13Health News:MedCath Corporation Reports First Quarter Earnings 14
(Date:1/23/2015)... MOINES, Iowa , Jan. 23, 2015  The Partnership to Fight ... Iowa health care leaders and a new study analyzing ... medications. The PFCD is a nationwide coalition working to educate policy ... research released at the Capitol was focused on how the ...
(Date:1/23/2015)... Jan. 23, 2015  Northwest Biotherapeutics, Inc. (NASDAQ: NWBO ... therapies for operable and inoperable solid tumor cancers, announced today ... 7 th Annual Phacilitate Immunotherapy Forum in ... Phacilitate will take place on January 26 at 10:30 a.m. ...
(Date:1/23/2015)... , Jan. 23, 2015 More than a third of ... of those with private insurance, filled a prescription for an ... report in this week,s Morbidity and Mortality Weekly Report (MMWR). ... providers to treat moderate to severe pain.  They are also ...
Breaking Medicine Technology:New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3
... Show 26% Partial Response, 63% Clinical Benefit ... ... Kosan Biosciences,Incorporated (Nasdaq: KOSN ) today announced that its lead ... Phase 2,trial when administered in combination with trastuzumab (Herceptin(R)) to,patients with ...
... Antitumor Activity Demonstrated in Metastatic Breast Cancer Patients, ... ENMD ), a clinical-stage pharmaceutical company developing,therapeutics ... today,announced the presentation of clinical data for the ... cancer. The data were presented by Bryan P.,Schneider, ...
Cached Medicine Technology:Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breast Cancer in a Phase 2 Trial 2Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breast Cancer in a Phase 2 Trial 3Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breast Cancer in a Phase 2 Trial 4Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breast Cancer in a Phase 2 Trial 5Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breast Cancer in a Phase 2 Trial 6EntreMed Presents MKC-1 Phase 2 Data at American Society of Clinical Oncology Annual Meeting 2EntreMed Presents MKC-1 Phase 2 Data at American Society of Clinical Oncology Annual Meeting 3EntreMed Presents MKC-1 Phase 2 Data at American Society of Clinical Oncology Annual Meeting 4
... the Penilab IV and the Penilab V have an ... Model 1060 is similar to the Model 1061 shown ... one be added later. The Penilab V has ... of the accessories you'll need to get started. ...
... specialty drapes for use in ... prevention fabric creates a barrier ... the need for multiple drapes. ... tape, Hand towels, Leggings (pair), ...
The Model 240 is a single-channel instrument designed for penile tumescence monitoring. It features exceptional stability. It's ready for use with most multi-channel recorders having a DC input....
... optical performance, the ALM X'Ten is a ... types of applications. , ,Its unique cross-shaped ... the highest standards needed for your surgical ... within the surgical field., ,A 31" column ...
Medicine Products: